Skip to main content

Blepharitis News

FDA Approves Xdemvy (lotilaner) Ophthalmic Solution for the Treatment of Demodex Blepharitis

IRVINE, Calif., July 25, 2023 (GLOBE NEWSWIRE) – Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Eye Conditions